Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT00026299 2013-09-05

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

14 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00268255 2013-04-16

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00087334 2013-02-01

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Phase 1/2 Terminated

10 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00352105 2012-11-05

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

60 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00098462 2012-10-04

Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00212108 2012-04-02

A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

22 enrolled

Nasopharyngeal Carcinoma

NCT00113529 2011-08-29

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

42 enrolled 35 charts

Genitourinary

Carcinoma, Renal Cell

NCT00238628 2010-07-20

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

12 enrolled

Lung Neoplasms

NCT00234416 2009-04-23

IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer

45 enrolled

Pancreatic Neoplasms

NCT00237900 2009-04-23

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Phase 1/2 Terminated

34 enrolled

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

NCT00239291 2009-04-23

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

42 enrolled

Genitourinary

Non-Metastatic Prostate Cancer

NCT00242788 2009-04-23

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

40 enrolled

Colorectal Neoplasms

NCT00239304 2007-12-18

Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer

40 enrolled

Head and Neck Neoplasms

NCT00195078 2007-07-20

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Phase 1/2 Terminated

29 enrolled